Total employees
408
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company founded in 2008, focusing on the development of first-in-class drugs against nuclear transport targets for cancer and other diseases. It specializes in SINE technology, aimed at inhibiting exportins, notably XPO1. Its lead product, Selinexor, targets multiple hematological and solid tumor malignancies.
Explore more companies
Oops! Something went wrong while submitting the form.
Clay Templates
Find more company data using our pre-built Clay templates.
Find Key Decision Makers
Find Number of Open Roles
Find International Employees
See all templates
Learn Clay
Go to our University library to get started and learn with our tutorials.
See all our tutorials
Historical Data
employee per department